ATE443160T1 - Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas- suszeptibilitätssgen und dessen verwendung - Google Patents

Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas- suszeptibilitätssgen und dessen verwendung

Info

Publication number
ATE443160T1
ATE443160T1 AT05764662T AT05764662T ATE443160T1 AT E443160 T1 ATE443160 T1 AT E443160T1 AT 05764662 T AT05764662 T AT 05764662T AT 05764662 T AT05764662 T AT 05764662T AT E443160 T1 ATE443160 T1 AT E443160T1
Authority
AT
Austria
Prior art keywords
obesity
voltage
gene encoding
susceptibility gene
potassium channel
Prior art date
Application number
AT05764662T
Other languages
English (en)
Inventor
Anne Philippi
Francis Rousseau
Elke Roschmann
Original Assignee
Integragen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Integragen Sa filed Critical Integragen Sa
Application granted granted Critical
Publication of ATE443160T1 publication Critical patent/ATE443160T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Electrotherapy Devices (AREA)
  • Eye Examination Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05764662T 2004-06-14 2005-06-14 Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas- suszeptibilitätssgen und dessen verwendung ATE443160T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57882904P 2004-06-14 2004-06-14
PCT/IB2005/002356 WO2005123949A2 (en) 2004-06-14 2005-06-14 Human obesity susceptibility gene encoding a potassium voltage-gated channel and uses thereof

Publications (1)

Publication Number Publication Date
ATE443160T1 true ATE443160T1 (de) 2009-10-15

Family

ID=35395853

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05764662T ATE443160T1 (de) 2004-06-14 2005-06-14 Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas- suszeptibilitätssgen und dessen verwendung

Country Status (10)

Country Link
US (1) US20080193923A1 (de)
EP (1) EP1756316B1 (de)
JP (1) JP2008502341A (de)
AT (1) ATE443160T1 (de)
AU (1) AU2005254806B2 (de)
CA (1) CA2568957A1 (de)
DE (1) DE602005016676D1 (de)
DK (1) DK1756316T3 (de)
IL (1) IL179744A0 (de)
WO (1) WO2005123949A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113671179B (zh) * 2021-09-02 2023-10-03 中国科学院深圳先进技术研究院 一种kcnab2自身抗体的检测用试剂盒及其检测方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252922A (en) * 1991-04-30 1993-10-12 Hewlett-Packard Company Radiofrequency focusing of magnetic resonance images
US5221900A (en) * 1991-04-30 1993-06-22 Hewlett-Packard Company Magnet structure for focusing of magnetic resonance images
US5185573A (en) * 1991-04-16 1993-02-09 Hewlett-Packard Company Method for focusing of magnetic resonance images
US6477398B1 (en) * 1997-11-13 2002-11-05 Randell L. Mills Resonant magnetic susceptibility imaging (ReMSI)
AU2001245489A1 (en) * 2000-03-07 2001-09-17 Whitehead Institute For Biomedical Research Human single nucleotide polymorphisms
US6682888B1 (en) * 2000-05-05 2004-01-27 Incyte Corporation Genes expressed in alzheimer's disease
WO2002028999A2 (en) * 2000-10-03 2002-04-11 Gene Logic, Inc. Gene expression profiles in granulocytic cells
WO2004035755A2 (en) * 2002-10-16 2004-04-29 Incyte Corporation Transporters and ion channels

Also Published As

Publication number Publication date
EP1756316A2 (de) 2007-02-28
AU2005254806B2 (en) 2009-06-04
WO2005123949A2 (en) 2005-12-29
DK1756316T3 (da) 2010-01-18
EP1756316B1 (de) 2009-09-16
IL179744A0 (en) 2007-05-15
JP2008502341A (ja) 2008-01-31
US20080193923A1 (en) 2008-08-14
CA2568957A1 (en) 2005-12-29
DE602005016676D1 (de) 2009-10-29
WO2005123949A3 (en) 2006-03-16
AU2005254806A1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
Apostolova et al. Associations of the top 20 Alzheimer disease risk variants with brain amyloidosis
Carrasquillo et al. Replication of CLU, CR1, and PICALM associations with alzheimer disease
Ghani et al. Association of long runs of homozygosity with Alzheimer disease among African American individuals
DE602005004026D1 (de) Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen
WO2006087634A3 (en) Uses of human autism susceptibility gene encoding a kinase
Penfold et al. Pediatric uptake of a newly available antipsychotic medication
ATE424469T1 (de) Für prkcb1 kodierendes humanes autismus- suszeptibilitätsgen und dessen verwendung
ATE443160T1 (de) Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas- suszeptibilitätssgen und dessen verwendung
DE602006017045D1 (de) Ein transmembranprotein kodierendes humanes autismus-suszeptibilitätsgen und dessen verwendung
DK1504125T3 (da) Humant fedmemodtagelighedsgen og anvendelser deraf
WO2005021787A3 (en) Human obesity susceptibility gene and uses thereof
WO2005090600A3 (en) Human obesity susceptibility genes encoding peptide hormones and uses thereof
Johnson Commercial viability of CNS drugs: Balancing the risk/reward profile
Kubarieva et al. Marketing investigation of preventive therapy of patients with multiple sclerosis
Batta et al. IL-17 and-23 Inhibitors for the Treatment of Psoriasis
Makaryan et al. Clinical outcomes for patients with severe chronic neutropenia due to mutations in the gene for neutrophil elastase, ELANE
Wolthers et al. Common Genetic Variants in Trypsin Regulating Genes Are Associated with AsparAginase-Associated Pancreatitis in Children with Acute Lymphoblastic Leukemia: A Ponte Di Legno Toxicity Working Group Study
Lee et al. International variation in severe exacerbation rates in patients with severe asthma
WO1999045112A3 (en) Chromosome 11-linked coronary heart disease susceptibility gene chd1
Robinson Jr et al. Economic burden of relapsed or refractory multiple myeloma: results from an international trial
Amaeshi et al. A Study Evaluating Financial Toxicity Amongst Hematologic Malignancy Patients in the Bronx
Horner et al. Adherence to inhaled therapy and mortality in COPD
Nair et al. Erythropoetin (EPO) and granulocyte colony stimulating factor (GCS-F) based therapy in patients with low risk MDS: A single centre experience from India.
Feld-Glazman et al. Poster 87 The impact of a stroke education program on Patient's stroke knowledge and their change of stroke risk behaviors
Elborn et al. Advanced curriculum for cystic fibrosis: Integrating genomic-driven data into patient-centered treatment strategies

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1756316

Country of ref document: EP

REN Ceased due to non-payment of the annual fee